ArticleDiabetology & metabolic syndrome2025
Comparison of gastric mucosa microbiota in metabolically healthy and unhealthy obesity.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPrevious studies have established a strong link between intestinal microbiota and metabolism. However, no research has examined the relationship between the gastric microbiome and metabolism status. This study characterizes the gastric microbiome in patients with metabolically healthy obesity (MHO) and compares it with that of patients with metabolically unhealthy obesity (MUO).
methodsGastric microbiota composition was analyzed using deep sequencing of the 5-region (5R) 16 S ribosomal RNA (16 S rRNA) gene.
resultsThe gastric microbiota profiles of MHO differed significantly from those of MUO. PICRUSt functional inference revealed distinct microbial metabolic pathways between the groups. PICRUSt analysis identified 30 differentially regulated pathways, with arginine, proline, tryptophan, and phenylalanine metabolism upregulated in MUO. By contrast, DNA repair and recombination proteins, ribosomes, amino acid-related enzymes, and ribosome biogenesis (KEGG Level 3) were upregulated in MHO.
conclusionThis study reveals significant differences in the gastric microbiome between MHO and MUO, highlighting the intricate relationship between microbiota composition and metabolic health. These findings suggest potential microbiome-based therapeutic targets for metabolic disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.